A detailed history of Fmr LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Fmr LLC holds 237,663 shares of ORGO stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
237,663
Previous 243,478 2.39%
Holding current value
$1.15 Million
Previous $779,000 31.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

SELL
$2.89 - $6.21 $16,805 - $36,111
-5,815 Reduced 2.39%
237,663 $1.03 Million
Q4 2024

Feb 13, 2025

BUY
$2.77 - $4.43 $193,575 - $309,581
69,883 Added 40.26%
243,478 $779,000
Q3 2024

Nov 13, 2024

BUY
$2.42 - $3.24 $106,961 - $143,204
44,199 Added 34.16%
173,595 $496,000
Q2 2024

Aug 13, 2024

BUY
$2.28 - $3.03 $102,016 - $135,574
44,744 Added 52.86%
129,396 $362,000
Q1 2024

May 13, 2024

SELL
$2.61 - $4.49 $1,297 - $2,231
-497 Reduced 0.58%
84,652 $240,000
Q4 2023

Feb 13, 2024

SELL
$1.97 - $4.21 $2,263 - $4,837
-1,149 Reduced 1.33%
85,149 $348,000
Q3 2023

Nov 13, 2023

SELL
$2.34 - $4.43 $699 - $1,324
-299 Reduced 0.35%
86,298 $274,000
Q2 2023

Aug 11, 2023

BUY
$1.9 - $4.3 $158,701 - $359,166
83,527 Added 2720.75%
86,597 $287,000
Q1 2023

May 11, 2023

BUY
$1.89 - $2.93 $2,621 - $4,063
1,387 Added 82.41%
3,070 $6,000
Q4 2022

Feb 13, 2023

SELL
$2.48 - $3.43 $2,539 - $3,512
-1,024 Reduced 37.83%
1,683 $4,000
Q3 2022

Nov 10, 2022

SELL
$3.14 - $6.43 $1,818 - $3,722
-579 Reduced 17.62%
2,707 $9,000
Q2 2022

Aug 12, 2022

SELL
$4.74 - $8.15 $42,370 - $72,852
-8,939 Reduced 73.12%
3,286 $16,000
Q1 2022

May 13, 2022

SELL
$6.47 - $9.57 $5.14 Million - $7.6 Million
-794,175 Reduced 98.48%
12,225 $93,000
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $391,468 - $585,900
43,400 Added 5.69%
806,400 $7.45 Million
Q3 2021

Nov 15, 2021

BUY
$13.71 - $17.18 $10.5 Million - $13.1 Million
763,000 New
763,000 $10.9 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $631M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.